Guggenheim Capital LLC Trans Medics Group, Inc. Transaction History
Guggenheim Capital LLC
- $14 Billion
- Q3 2024
A detailed history of Guggenheim Capital LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Guggenheim Capital LLC holds 2,048 shares of TMDX stock, worth $155,729. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,048Holding current value
$155,729% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TMDX
# of Institutions
396Shares Held
31.9MCall Options Held
466KPut Options Held
286K-
Vanguard Group Inc Valley Forge, PA3.6MShares$273 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$201 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL1.44MShares$110 Million2.22% of portfolio
-
State Street Corp Boston, MA1.27MShares$96.8 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.09MShares$83.2 Million0.03% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $2.42B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...